Navigation Links
Dr. Brad Vince, with Vince and Associates Clinical Research, Presents at the Exploratory Development World Congress 2009

OVERLAND PARK, Kan., Nov. 2 /PRNewswire/ -- Vince and Associates Clinical Research (VACR), a leading provider of Phase I-IV clinical research trials, announced that Dr. Bradley Vince, Medical Director and President, shared his expertise at the Exploratory Development World Congress on October 20, 2009 in Boston, Massachusetts. The Exploratory Development World Americas Congress focuses on early development strategy, including a wide range of disciplines within clinical trials including Clinical Research, Clinical Pharmacology, Phase I Trials, Exploratory Development, Regulatory Affairs, PK/PD and Clinical Operations.

The pre-conference workshop facilitated by Lorraine M. Rusch, PhD, Vice President of Business Development at VACR, was entitled Mitigating Risk in Early Clinical Development. During the session, Dr. Vince discussed Recruiting Strategies and Medical Oversight of Special Population Volunteers in Early Stage Trials. Dr. Vince related his physician perspective on the recruitment and medical management of intent-to-treat populations during early clinical research trials which enable earlier Proof of Concept (POC) drug development data to be successfully obtained.

"As a multi-specialty research unit, Vince and Associates Clinical Research is a leading provider of Phase I-IV clinical research for the pharmaceutical and biotechnology industry," said Dr. Vince. "We welcomed the opportunity to share our perspective, medical expertise and strength in early-stage drug development data at the Exploratory Development World Congress."

As the Medical Director of the Vince and Associates Clinical Research, Dr. Vince provides overall management of Phase I-IV clinical pharmacology services, including study design, feasibility, recruiting and monitoring of both healthy normal subjects and special population patients participating in clinical trials at the Overland Park, Kansas facilities.

Vince and Associates Clinical Research is a dedicated research facility that conducts Phase I-IV clinical trials for the global pharmaceutical and biotech industry. Dr. Vince has personally assembled an experienced team that focuses on quality research data and exceptional customer service while maintaining the highest ethical and professional standards. Vince and Associates has become one of the premier U.S. clinical research sites specializing in multispecialty trials. With over 275 clinical trials completed and having worked with over 70 sponsors and CROs, Vince and Associates is well known and respected for its rapid study start-up and quality study data.

Additional background materials pertaining to Vince and Associates Clinical Research is located on the corporate website at

    Bruce Copeland

SOURCE Vince and Associates Clinical Research

SOURCE Vince and Associates Clinical Research
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Vincent W. Renz Joins NewCardio as President
2. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
3. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc.
4. Tata Interactive Systems Partners With Bersin & Associates for Exclusive Executive Learning Forum - TLF 2009
5. Physiotherapy Associates Marks National Physical Therapy Month With Free Educational Brochure
6. Aprimas EHR Helps Bend Urology Associates Improve Efficiency, Workflow
7. Press Ganey Partners With Health Management Associates
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
10. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
11. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
Post Your Comments:
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/19/2017)... 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically ... announced three leadership team developments today:   ... ... Tom ... Veteran medical device executive Josh Stopek , PhD, who ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and fastest ... to open a flagship location in Covington, LA at 401 N. U.S. Highway 190, ... next to Office Depot in the Holiday Square shopping center. Its location allows it ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized health ... expanded their existing home health joint venture through an agreement, effective October 1, ... joint venture home health company with Asante, delivering clinically integrated care, for the ...
(Date:10/12/2017)... LOS ANGELES (PRWEB) , ... October 12, 2017 ... ... of Parsa Mohebi Hair Restoration, has recently contributed a medical article to the ... doctors, on Dr. Mohebi’s article spotlights the hair transplant procedure known as ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
Breaking Medicine News(10 mins):